 Opportunity to invest in carefully selected portfolio of innovative, early-stage life sciences companies developing cutting-edge technologies is now open to eligible investors. InnoCom Bio Equities, Inc. InnoCom focuses on bringing equity and early commercialization to innovative best-in-class life science ventures. San Francisco, California, USA, Dec. 12, 2022 GLOBE NEWSWIRE US Capital Global Securities LLC, ... The post US Capital Global Securities Launches 250 Million Equity Offering for... 